Gwo‐Yaw Ho

1.8k citations
18 papers · 389 indexed · h-index 7
Topics
Ovarian cancer diagnosis and treatment (4 papers)PARP inhibition in cancer therapy (3 papers)Cancer Treatment and Pharmacology (2 papers)

In The Last Decade

Gwo‐Yaw Ho

17 papers receiving 388 citations

Peers

Gwo‐Yaw Ho
Comparison fields: 5 of 72
  • Oncology 184
  • Molecular Biology 133
  • Pulmonary and Respiratory Medicine 78
  • Immunology 57
  • Cancer Research 57
Replace Gustavo Ismael with:
Gustavo Ismael Belgium
Pauline A. Whitehouse United Kingdom
Carolina Hassibe Thomé Brazil
Zheng Su China
Melissa Nelson United States
Rukh Yusuf United States
Mihaela Popa Norway
Delphine Quatannens Belgium
Pamela Maris Italy
Adam Kresak United States
Gwo‐Yaw Ho relative to Gustavo Ismael Belgium Gustavo Ismael's profile →
Citations per field
00.5×4.8×
Gustavo Ismael · 1×
Citations per year

Countries citing papers authored by Gwo‐Yaw Ho

Since Specialization
Citations

This map shows the geographic impact of Gwo‐Yaw Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gwo‐Yaw Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gwo‐Yaw Ho more than expected).

Fields of papers citing papers by Gwo‐Yaw Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gwo‐Yaw Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gwo‐Yaw Ho. The network helps show where Gwo‐Yaw Ho may publish in the future.

Co-authorship network of co-authors of Gwo‐Yaw Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Gwo‐Yaw Ho. A scholar is included among the top collaborators of Gwo‐Yaw Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gwo‐Yaw Ho. Gwo‐Yaw Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 1
2 2
3 7
4 0
5 4
6 1
7 1
8 30
9 14
10
Chaperone-mediated protein degradation (CHAMP): A novel technology for tumor-targeted protein degradation.
2
11 37
12 2
13 26
14 1
15
SRA737, a novel Chk1 inhibitor, shows efficacy in CCNE1-amplified and MYCN-overexpressing high-grade serous ovarian cancer patient-derived xenograft models
1
16 230
17 3
18 27

About Gwo‐Yaw Ho

Gwo‐Yaw Ho is a scholar working on Reproductive Medicine, Oncology and Cancer Research, having authored 18 papers that have together received 389 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (4 papers), PARP inhibition in cancer therapy (3 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Oncology (184 citations), Cancer Research (57 citations) and Reproductive Medicine (29 citations). Gwo‐Yaw Ho has collaborated with scholars based in Australia, United States and Netherlands. Frequent co-authors include Jermaine Coward, Natasha Woodward, Joshua D. Ooi, Clare L. Scott, Kim M. O’Sullivan, Anthony T. Papenfuss, Jessica Wu, Daphne Day, Gerard G. Hanna and Michelle White. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026